Clinical Trials Browser

Phase 1/2 × TAK-981 × 1 year × Clear all

NCT04381650 2025-12-10

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

161 enrolled 44 charts

Other solid neoplasm

Advanced or Metastatic Solid Tumors